The Foundation for Sarcoidosis Research is dedicated to the health and safety of our patients. Since the COVID-19 vaccines have been released for distribution, we have received a lot of questions. We continue to monitor this situation and want to provide you who the...
FSR is thrilled to have a wonderful lineup of speakers and presenters joining us for our upcoming virtual educational summit that is taking place this Saturday, November 14th! Check out which institutions will be represented, see the full schedule Register...
The following is an exciting announcement from an FSR partner, Boehringer Ingelheim – see the release on their website here. Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19...
COVID-19 has changed our world. As of October 1, 2020, the Johns Hopkins University Coronavirus Resource Center reported over 35.5 million individuals worldwide have been infected with COVID-19, including over 7 million in the United States. There are about 200,000...
The Foundation for Sarcoidosis Research, the leading nonprofit organization dedicated to advancing research and improving care for individuals living with sarcoidosis, announces Mary McGowan as the organization’s first-ever Chief Executive Officer. With more...
FSR’s Small Grant Program The FSR Small Grant aims to support smaller scale or pilot research projects, which can be supported either singularly by FSR or through a partnership with additional funders. The goal of this program is to provide bridge funding for...
FSR’s Virtual Summits this Fall will be day-long, comprehensive educational and wellness events. While they will be held entirely online, the Summits will still have plenty of opportunities to interact with other sarcoidosis warriors via chat rooms and our...
FSR launched its Clinical and Research Fellowship Program in Fall 2017. We’ve invested over $1 million into this program, which aims to increase the number of specialized doctors and researchers in the sarcoidosis space. This investment in early career...
FSR has spent 20 years serving sarcoidosis patients and their families, as well as the healthcare providers and researchers who dedicate their careers to fighting sarcoidosis. In response to the inequitable treatment of Black individuals in America, we want to...
FSR has made the decision to transition our in-person Patient Education Summits to be Virtual Summits. This decision was made due to the ongoing challenges of the COVID-19 pandemic in order to be proactive about the health and comfort of our community. While we are...
